Cited by 34Diabetes Management and EducationDiabetes Management and ResearchHealth Promotion and Cardiovascular Prevention

Characteristics of Insured Patients With Persistent Gaps in Diabetes Care Services: The Translating Research into Action for Diabetes (TRIAD) Study

Open access
Gregg, Edward W., Karter, Andrew J., Gerzoff, Robert B., Safford, Monika, Brown, Arleen F., Tseng, Chien-Wen, Waitzfielder, Beth, Herman, William H. +4 more·2010·Medical Care

Abstract

BACKGROUND: Although preventing diabetes complications requires long-term management, little is known about which patients persistently fail to get recommended care. OBJECTIVE: To determine the frequency and correlates of persistent, long-term gaps in diabetes care. METHOD: : The study population included 8392 patients with diabetes. Patient surveys and medical records from 10 health plans over 3 years provided data on socioeconomic characteristics, access to care, social support, and mental and physical health, and diabetes preventive care services. We defined a "persistent gap" as a participant's missing a preventive care service for the entire 3 years. Services considered included hemoglobin A1c, cholesterol, and albuminuria tests, and foot and dilated eye examinations. RESULTS: Thirty percent of participants had at least 1 persistent gap. The most common gaps were lipid testing (11.6%), microalbuminuria testing (9.7%), and eye examinations (9.0%). Persistent gaps were 18% to 42% higher for young patients, lean persons, those with low income, employed persons, smokers, those with diabetes less than 5 years, and patients with none or 1 comorbid conditions. Sex, education, marital status, family demands, transportation, trust in physicians, and mental health were not associated with gaps in care. CONCLUSIONS: Persistent gaps in diabetes care are common even among insured patients. Patients with lower income, younger age, fewer years of diabetes, having fewer comorbidities, taking fewer medications, and poor health behaviors are vulnerable to persistent gaps in care and a group who warrant targeted interventions to improve preventive diabetes care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mlr.0b013e3181bd4783

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients' experience of health care is affected by perceived discrimination, resulting in distrust in the provider and, potentially, racial concordance with providers.

    “Patients' experience of health care is also affected by perceived discrimination, resulting distrust in the provider, and, potentially, racial concordance with providers [47-51].”

    From Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai’i and California (2023) · cites this paper as [48]

    The Results discuss differences in missed diabetes services by patient race/ethnicity, while the Discussion says the study did not examine the relative impact of provider practices and perceptions on persistent lapses. Searches for discrimination, distrust, and racial concordance found no passage linking them to patients’ experience of care. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. [1]Engelgau MM Geiss LS Saaddine JB The evolving diabetes burden in the United States Ann Intern Med 2004 140 11 945 950 15172919
  2. [2]Norris SL Nichols PJ Caspersen CJ The effectiveness of disease and case management for people with diabetes. A systematic review Am J Prev Med 2002 22 4 Suppl 15 38 11985933
  3. [3]Fleming BB Greenfield S Engelgau MM The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic Diabetes Care 2001 24 10 1815 1820 11574448
  4. [4]Acton KJ Shields R Rith-Najarian S Applying the diabetes quality improvement project indicators in the Indian Health Service primary care setting Diabetes Care 2001 24 1 22 26 11194234
  5. [5]Saaddine JB Engelgau MM Beckles GL A diabetes report card for the United States: quality of care in the 1990s Ann Intern Med 2002 136 8 565 574 11955024
  6. [6]Selby JV Ray GT Zhang D Excess costs of medical care for patients with diabetes in a managed care population Diabetes Care 1997 20 9 1396 1402 9283786
  7. [7]Preventive-care practices among persons with diabetes--United States, 1995 and 2001 MMWR Morb Mortal Wkly Rep 2002 51 43 965 969 12433019
  8. [8]Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial Am J Cardiol 1995 75 14 894 903 7732997
  9. [9]Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group BMJ 1998 317 7160 703 713 9732337 PMC28659
  10. [10]Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study JAMA 2003 290 16 2159 2167 14570951 PMC2622725
  11. [11]Krein SL Hofer TP Kerr EA Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities Health Serv Res 2002 37 5 1159 1180 12479491 PMC1464024
  12. [12]Gregg EW Geiss LS Saaddine J Use of diabetes preventive care and complications risk in two African-American communities Am J Prev Med 2001 21 3 197 202 11567840
  13. [13]Saaddine JB Cadwell B Gregg EW Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002 Ann Intern Med 2006 144 7 465 474 16585660
  14. [15]Safran DG Kosinski M Tarlov AR The Primary Care Assessment Survey: tests of data quality and measurement performance Med Care 1998 36 5 728 739 9596063
  15. [16]Ware J Jr Kosinski M Keller SD A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 1996 34 3 220 233 8628042
  16. [18]Charlson ME Pompei P Ales KL A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 1987 40 5 373 383 3558716
  17. [20]Graubard BI Korn EL Predictive margins with survey data Biometrics 1999 55 2 652 659 11318229
  18. [21]Schafer JL Multiple imputation: a primer Stat Methods Med Res 1999 8 1 3 15 10347857
  19. [23]Rubin DB Schenker N Multiple imputation in health-care databases: an overview and some applications Stat Med 1991 10 4 585 598 2057657
  20. [24]Brown AF Ettner SL Piette J Socioeconomic Position and Health among Persons with Diabetes Mellitus: A Conceptual Framework and Review of the Literature Epidemiol Rev 2004 26 1 63 77 15234948
  21. [25]Selby JV Swain BE Gerzoff RB Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD) Med Care 2007 45 12 1144 1153 18007164
  22. [26]Chaturvedi N Stephenson JM Fuller JH The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study Diabetes Care 1995 18 6 785 792 7555504
  23. [27]Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes JAMA 2002 287 19 2542 2551 12020335
  24. [28]Zhang P Engelgau MM Norris SL Application of economic analysis to diabetes and diabetes care Ann Intern Med 2004 140 11 972 977 15172923
  25. [29]Polak BC Crijns H Casparie AF Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy Health Policy 2003 64 1 89 97 12644331
  26. [30]Vijan S Hofer TP Hayward RA Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus JAMA 2000 283 7 889 896 10685713
  27. [31]Tseng CW Tierney EF Gerzoff RB Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study Diabetes Care 2008 31 2 261 266 18000177

Cited by

Sorted by citations

Authors
Gregg, E. W., Karter, A. J., Gerzoff, R. B., Safford, M., Brown, A. F., Tseng, C.-W., Waitzfielder, B., Herman, W. H., Mangione, C. M., Selby, J. V., Thompson, T. J., & Dudley, R. A.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Kaiser Permanente (US)
  • University of Alabama at Birmingham (US)
  • University of California, Los Angeles (US)
  • University of Hawaiʻi at Mānoa (US)
  • Pacific Health Research and Education Institute (US)
Corresponding author
  • Gregg, Edward W.
  • Gerzoff, Robert B.
  • Herman, William H.
  • Thompson, Theodore J.
Venue
Medical Care
Published
2010-01
Volume
48
Issue
1
Pages
31-37
ISSN
0025-7079 (ISSN-L)
OpenAlex
W2030152347
Cited by
34
References
2
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2017: 4 · 2016: 4 · 2014: 7
FWCI
1.94
Type
journal article
Language
en
Open access
Locations
  • Medical Care (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Centers for Disease Control and Prevention
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081796)
  • National Center for Chronic Disease Prevention and Health Promotion (U58 DP002641)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
preventive medicine, insured patients, health insurance, socioeconomic factors, low income, comorbidities, lipid testing, microalbuminuria, eye examination, foot examination, HbA1c, health care access, health behavior, diabetes complications
MeSH terms
Age Factors, Aged, Diabetes Mellitus, Female, Humans, Insurance Claim Review, Insurance, Health, Male, Middle Aged, Primary Prevention, Sex Factors, Smoking, Socioeconomic Factors, Time Factors, Health Behavior, Comorbidity, Body Mass Index, Insurance Coverage, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review